Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Marsden

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Nature Chemistry|August 24, 2012
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitroBrian A DeChristopher, Brian A Loy, Matthew D Marsden, et al.
Virology|February 26, 2023
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversalJose A Moran, Alok Ranjan, Rami Hourani, et al.
Stem Cells (Dayton, Ohio)|November 1, 2008
Generation of T lineage cells from human embryonic stem cells in a feeder free systemZoran Galić, Scott G Kitchen, Aparna Subramanian, et al.
Journal of Stem Cells|May 26, 2010
Macrophage differentiation from embryoid bodies derived from human embryonic stem cellsAparna Subramanian, Beichu Guo, Matthew D Marsden, et al.
Journal of Virology|November 11, 2011
HIV latency in the humanized BLT mouseMatthew D Marsden, Michael Kovochich, Nuttee Suree, et al.
Science Advances|January 24, 2025
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIVZachary O Gentry, Owen D McAteer, Jennifer L Hamad, et al.
Pathogens & Immunity|May 20, 2024
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer CellsMelanie Dimapasoc, Jose A Moran, Steve W Cole, et al.
Nature Communications|April 22, 2020
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapyClayton Hardman, Stephen Ho, Akira Shimizu, et al.
Molecular Therapy. Nucleic Acids|February 18, 2015
RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT MiceSaki Shimizu, Gene-Errol Ringpis, Matthew D Marsden, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2013
Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivoElizabeth J Beans, Dennis Fournogerakis, Carolyn Gauntlett, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Nature Chemistry|August 24, 2012
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitroBrian A DeChristopher, Brian A Loy, Matthew D Marsden, et al.
Virology|February 26, 2023
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversalJose A Moran, Alok Ranjan, Rami Hourani, et al.
Stem Cells (Dayton, Ohio)|November 1, 2008
Generation of T lineage cells from human embryonic stem cells in a feeder free systemZoran Galić, Scott G Kitchen, Aparna Subramanian, et al.
Journal of Stem Cells|May 26, 2010
Macrophage differentiation from embryoid bodies derived from human embryonic stem cellsAparna Subramanian, Beichu Guo, Matthew D Marsden, et al.
Journal of Virology|November 11, 2011
HIV latency in the humanized BLT mouseMatthew D Marsden, Michael Kovochich, Nuttee Suree, et al.
Science Advances|January 24, 2025
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIVZachary O Gentry, Owen D McAteer, Jennifer L Hamad, et al.
Pathogens & Immunity|May 20, 2024
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer CellsMelanie Dimapasoc, Jose A Moran, Steve W Cole, et al.
Nature Communications|April 22, 2020
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapyClayton Hardman, Stephen Ho, Akira Shimizu, et al.
Molecular Therapy. Nucleic Acids|February 18, 2015
RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT MiceSaki Shimizu, Gene-Errol Ringpis, Matthew D Marsden, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2013
Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivoElizabeth J Beans, Dennis Fournogerakis, Carolyn Gauntlett, et al.
Pageof 5